MXCT

MaxCyte (MXCT)

About MaxCyte (MXCT)

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.

Details

Daily high

$3.87

Daily low

$3.73

Price at open

$3.85

52 Week High

$5.54

52 Week Low

$2.84

Market cap

397.2M

Dividend yield

0.00%

Volume

178,292

Avg. volume

343,035

P/E ratio

-11.09

MaxCyte News